Cas9BCL11A

Matthew C Canver1, Elenoe C Smith1, Falak Sher1

  • 1Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature
|September 17, 2015
PubMed
概括

研究人员使用集成的CRISPR- Cas9查绘制了BCL11A红细胞增强剂的关键特征. 这项研究验证了增强剂作为重新诱导胎儿血红蛋白的目标,为未来的基因组编辑疗法提供了信息.